Related references
Note: Only part of the references are listed.Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study
Peter A. Campochiaro et al.
HUMAN GENE THERAPY (2017)
Global Manufacturing of CAR T Cell Therapy
Bruce L. Levine et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy
Michela Milani et al.
EMBO MOLECULAR MEDICINE (2017)
Future directions in chimeric antigen receptor T cell therapy
Shannon L. Maude
CURRENT OPINION IN PEDIATRICS (2017)
HIV-1 Vpr- and Reverse Transcription-Induced Apoptosis in Resting Peripheral Blood CD4 T Cells and Protection by Common Gamma-Chain Cytokines
Benjamin Trinite et al.
JOURNAL OF VIROLOGY (2016)
Cellular and viral determinants of retroviral nuclear entry
Faysal Bin Hamid et al.
CANADIAN JOURNAL OF MICROBIOLOGY (2016)
The benefits of integration
A. Ciuffi
CLINICAL MICROBIOLOGY AND INFECTION (2016)
CD19 CAR-T cells of defined CD4+: CD8+ composition in adult B cell ALL patients
Cameron J. Turtle et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial
Mario Sessa et al.
LANCET (2016)
Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes
Sheng Zhou et al.
MOLECULAR THERAPY (2016)
A Self-restricted CRISPR System to Reduce Off-target Effects
Yanhao Chen et al.
MOLECULAR THERAPY (2016)
Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo
Francesco R. Simonetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Innate immune defects in HIV permissive cell lines
Antonio Rausell et al.
RETROVIROLOGY (2016)
Production of lentiviral vectors
Otto-Wilhelm Merten et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Retroviral integration: Site matters: Mechanisms and consequences of retroviral integration site selection
Jonas Demeulemeester et al.
BIOESSAYS (2015)
NY-ESO T cells administered post ASCT for MM exhibit extended functionality without exhaustion in a natural pattern of effector and memory programming
Aaron Rapoport et al.
CANCER RESEARCH (2015)
Lentivirus-induced 'Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma
B. S. Sundarasetty et al.
GENE THERAPY (2015)
Lentiviral vectors in cancer immunotherapy
Robyn A. A. Oldham et al.
IMMUNOTHERAPY (2015)
Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes-Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
Dung T. Le et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Large-scale Clinical-grade Retroviral Vector Production in a Fixed-Bed Bioreactor
Xiuyan Wang et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Impact of Nucleoporin-Mediated Chromatin Localization and Nuclear Architecture on HIV Integration Site Selection
Richard W. Wong et al.
JOURNAL OF VIROLOGY (2015)
Nuclear architecture dictates HIV-1 integration site selection
Bruna Marini et al.
NATURE (2015)
HIV-1 capsid: the multifaceted key player in HIV-1 infection
Edward M. Campbell et al.
NATURE REVIEWS MICROBIOLOGY (2015)
Liver-directed lentiviral gene therapy in a dog model of hemophilia B
Alessio Cantore et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
3D hotspots of recurrent retroviral insertions reveal long-range interactions with cancer genes
Sepideh Babaei et al.
NATURE COMMUNICATIONS (2015)
Construction of stable packaging cell lines for clinical lentiviral vector production
Khaled S. Sanber et al.
SCIENTIFIC REPORTS (2015)
Reverse Transcription of Retroviruses and LTR Retrotransposons
Stephen H. Hughes
MICROBIOLOGY SPECTRUM (2015)
Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor
Fouzia Amirache et al.
BLOOD (2014)
Uncovering and Dissecting the Genotoxicity of Self-inactivating Lentiviral Vectors In Vivo
Daniela Cesana et al.
MOLECULAR THERAPY (2014)
Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library
Hiroko Koike-Yusa et al.
NATURE BIOTECHNOLOGY (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage
Nicolas Grandchamp et al.
PLOS ONE (2014)
Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
Thor A. Wagner et al.
SCIENCE (2014)
Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
F. Maldarelli et al.
SCIENCE (2014)
A model for cofactor use during HIV-1 reverse transcription and nuclear entry
Laura Hilditch et al.
CURRENT OPINION IN VIROLOGY (2014)
Patient monitoring and follow-up in lentiviral clinical trials
Gerard J. McGarrity et al.
JOURNAL OF GENE MEDICINE (2013)
LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus
Danit Finkelshtein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Wrapping up the bad news - HIV assembly and release
Bo Meng et al.
RETROVIROLOGY (2013)
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
Alessandro Aiuti et al.
SCIENCE (2013)
Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
Alessandra Biffi et al.
SCIENCE (2013)
Replication-Competent Retroviruses in Gene-Modified T Cells Used in Clinical Trials: Is It Time to Revise the Testing Requirements?
Adham S. Bear et al.
MOLECULAR THERAPY (2012)
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
Elena Provasi et al.
NATURE MEDICINE (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Directly Infected Resting CD4+T Cells Can Produce HIV Gag without Spreading Infection in a Model of HIV Latency
Matthew J. Pace et al.
PLOS PATHOGENS (2012)
PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells
Katarzyna Karwacz et al.
EMBO MOLECULAR MEDICINE (2011)
R5 HIV env and Vesicular Stomatitis Virus G Protein Cooperate To Mediate Fusion to Naive CD4(+) T Cells
Matthew J. Pace et al.
JOURNAL OF VIROLOGY (2011)
Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription
Amy E. Hulme et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity
Chuanfeng Wu et al.
Frontiers of Medicine (2011)
Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential
David Escors et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2010)
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana-Calvo et al.
NATURE (2010)
Reprogramming T Lymphocytes for Melanoma Adoptive Immunotherapy by T-Cell Receptor Gene Transfer with Lentiviral Vectors
Sara Bobisse et al.
CANCER RESEARCH (2009)
The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy
Eugenio Montini et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The CXCR4-Tropic Human Immunodeficiency Virus Envelope Promotes More-Efficient Gene Delivery to Resting CD4+ T Cells than the Vesicular Stomatitis Virus Glycoprotein G Envelope
Luis M. Agosto et al.
JOURNAL OF VIROLOGY (2009)
Nonintegrating Lentivector Vaccines Stimulate Prolonged T-Cell and Antibody Responses and Are Effective in Tumor Therapy
Katarzyna Karwacz et al.
JOURNAL OF VIROLOGY (2009)
Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors
Ute Modlich et al.
MOLECULAR THERAPY (2009)
Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
Michael C. Milone et al.
MOLECULAR THERAPY (2009)
Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells
Adlen Foudi et al.
NATURE BIOTECHNOLOGY (2009)
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Nathalie Cartier et al.
SCIENCE (2009)
Targeting dendritic cell signaling to regulate the response to immunization
David Escors et al.
BLOOD (2008)
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
Steven J. Howe et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells
Gabriela Plesa et al.
JOURNAL OF VIROLOGY (2007)
Targeted genome modifications using integrase-deficient lentiviral vectors
Tatjana I. Cornu et al.
MOLECULAR THERAPY (2007)
HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications
Gary P. Wang et al.
GENOME RESEARCH (2007)
HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore
Nathalie J. Arhel et al.
EMBO JOURNAL (2007)
Determination of the ex vivo rates of human immunodeficiency virus type 1 reverse transcription by using novel strand-specific amplification analysis
David C. Thomas et al.
JOURNAL OF VIROLOGY (2007)
Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules
Megan M. Suhoski et al.
MOLECULAR THERAPY (2007)
Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo
Stephanie Philippe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Wild-type and central DNA flap defective HIV-I lentiviral vector genomes: intracellular visualization at ultrastructural resolution levels
Nathalie J. Arhel et al.
RETROVIROLOGY (2006)
Retroviral DNA integration: Viral and cellular determinants of target- site selection
Mary K. Lewinski et al.
PLOS PATHOGENS (2006)
Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli
WJ Swiggard et al.
JOURNAL OF VIROLOGY (2005)
Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice
M Themis et al.
MOLECULAR THERAPY (2005)
Capsid is a dominant determinant of retrovirus infectivity in nondividing cells
M Yamashita et al.
JOURNAL OF VIROLOGY (2004)
Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain
V Baekelandt et al.
GENE THERAPY (2003)
Progress and problems with the use of viral vectors for gene therapy
CE Thomas et al.
NATURE REVIEWS GENETICS (2003)
Enhanced transgene expression in cord blood CD34+-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified TRIP lentiviral vectors
A Sirven et al.
MOLECULAR THERAPY (2001)
Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors
J Chen et al.
HUMAN GENE THERAPY (2001)